No coin nor oath required. For personal study only.
BASF is operating three plants for making chiral intermediates to meet rising demand from life science customers. The new plants reflect the advancement in the firm's proprietary technology and provide solutions to the limitations of previous plants in use. The active intermediates are used in making pharmaceutical and agrochemical compounds. The firm's 2500 tonne/y optically active amine plant in Gesmar, LA, produces the key ingredient for the firm's Outlook herbicide. The plant is based on a proprietary biocatalytic enzymatic process. The same technology is used in the multi-product cGMP plant in Ludwigshafen, Germany, which has a production capacity of over 1000 tonne/y. The third plant in Ludwigshafen uses a biocatalytic process to produce R-mandelic acid.
๐ SIMILAR VOLUMES
to immediately start construction work on the 15-month contract, worth up to US$65 million. The contract involves the construction of a 182 km, 24 inch pipeline from Al Ain to Qidfa, in Fujairah, and the construction of a pressure reducing metering station at Qidfa. The pipeline will have overall ca
company, of genetically engineered products that can generate enzymes that will break down cellulose is also noted.